The global CAR T-cell therapy market is projected to undergo substantial growth over the forecast period of 2023 to 2028. This phenomenon can be attributed to a number of factors, including rising prevalence of cancer, progresses in cell therapy technology, and positive regulatory approvals. The market is also stimulated by a increasing demand for